Schedule 13G ownership disclosure

Immix Biopharma, Inc.

Security class unavailable · CUSIP: 45258H106

Event date: 2021-12-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
674,383
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-21-012282
Form type
SC 13G
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Dec 28, 2021
Reporting period
Dec 16, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub